Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study investigates possible link between sleep apnea and autoimmune diseases

New research by University of Georgia scientists sheds light on why people with obstructive sleep apnea may have associated autoimmune disorders. The results could lead to better approaches to treatment and possibly new drug therapies.

17 Nov 2020

Investigational drug helped improve heart health in patients with chronic conditions

The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with Type 2 diabetes and chronic kidney disease, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Cynical hostility poses the greatest risk for cardiovascular disease

Cynical hostility is a potential pathway to cardiovascular disease by preventing a healthy response to stress over time, according to a study led by Baylor University.

17 Nov 2020

Short bursts of intense exercise could help people get fit in time for summer

Short bursts of intense exercise – known as HIIT – could help you get back into shape by summer and stay that way, a UNSW Sydney exercise physiology researcher says.

17 Nov 2020

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three blood pressure medications and a lipid lowering medication taken alone or with aspirin.

16 Nov 2020

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Even when risk factors associated with cardiovascular disease are optimally controlled, adults with Type 2 diabetes still have a greater risk of developing cardiovascular disease compared to the general population, according to new research published today in the American Heart Association's flagship journal Circulation.

16 Nov 2020

Metabolic biomarkers could predict COVID-19 severity

A new study suggests that metabolic biomarkers could possibly predict the severity of COVID-19 in patients.

16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

New drug reduces LDL cholesterol in patients with severe hypercholesterolemia

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called "bad" cholesterol--by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and other global academic sites has found.

16 Nov 2020

People taking placebo pills and statins experienced similar side effects, shows study

People taking dummy pills and statins experienced similar side effects in a new study.

15 Nov 2020

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Scientists in Taiwan recently published a report on their use of anti-neutrophil strategies to treat acute respiratory distress syndrome (ARDS) – a life-threatening condition that can arise in critical COVID-19 cases – in the journal Frontiers in Pediatrics.

15 Nov 2020

New screening strategy can help identify individuals with higher probability of developing heart disease

More than 40% of middle-aged adults have silent coronary artery disease. Researchers have developed a new screening questionnaire to help identify individuals at the highest risk for coronary artery disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

A single, daily pill combining blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking research presented today in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

Taking omega-3 fatty acids and vitamin D3 supplements does not neither increase nor decrease the risk of developing atrial fibrillation, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Exposure to air pollution during fetal period, early life linked with higher blood pressure

Exposure to an urban environment characterized by high levels of air pollution and noise in areas with a high building density during the fetal period and in early childhood may contribute to higher blood pressure.

12 Nov 2020

Post-COVID hospitalization has lasting impact on health, work

Surviving a case of COVID-19 that's bad enough to land you in the hospital is hard enough. But life after the hospital stay - and especially after an intensive care stay - is no bed of roses, either, according to a new study.

12 Nov 2020

Host genetic "super-variants" may increase COVID-19 death risk

Researchers at Yale University have identified genetic variants among people of white British ancestry that may increase the risk of dying from coronavirus disease 2019 (COVID-19) – the illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

11 Nov 2020

Rheumatoid arthritis may increase risk of dying from COVID-19

Researchers in New Zealand and Australia have conducted a study showing that people with rheumatoid arthritis may be at an increased risk of death if they develop coronavirus disease 2019 (COVID-19) after becoming infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

11 Nov 2020

Team sport improves blood pressure, vascular function in postmenopausal women

Team sport effectively counteracts diminished vascular function in women with high blood pressure, even several years after the onset of menopause.

11 Nov 2020

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study investigates possible link between sleep apnea and autoimmune diseases

Investigational drug helped improve heart health in patients with chronic conditions

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

Cynical hostility poses the greatest risk for cardiovascular disease

Short bursts of intense exercise could help people get fit in time for summer

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Metabolic biomarkers could predict COVID-19 severity

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

New drug reduces LDL cholesterol in patients with severe hypercholesterolemia

People taking placebo pills and statins experienced similar side effects, shows study

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

New screening strategy can help identify individuals with higher probability of developing heart disease

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

Exposure to air pollution during fetal period, early life linked with higher blood pressure

Post-COVID hospitalization has lasting impact on health, work

Host genetic "super-variants" may increase COVID-19 death risk

Rheumatoid arthritis may increase risk of dying from COVID-19

Team sport improves blood pressure, vascular function in postmenopausal women

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in